You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IDH-305

Showing 1 - 25 of 165
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignancies That Harbor IDHR132 Mutations Trial in Worldwide (IDH305)

Active, not recruiting
  • Advanced Malignancies That Harbor IDHR132 Mutations
  • Boston, Massachusetts
  • +12 more
Dec 9, 2021

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Biospecimen Collection
  • +2 more
  • Orange, California
  • +9 more
Jan 27, 2023

Acute Myeloid Leukemia (AML) Trial (IDH305)

Withdrawn
  • Acute Myeloid Leukemia (AML)
  • (no location specified)
Apr 8, 2019

Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Puerto Rico, United States (Ivosidenib)

Recruiting
  • Recurrent Ependymoma
  • +32 more
  • Birmingham, Alabama
  • +173 more
Jan 27, 2023

Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Costa Mesa, California
  • +49 more
Aug 24, 2022

Glioma, Brain Tumor, Primary Brain Tumor Trial in Miami (3T MRI Scanner)

Recruiting
  • Glioma
  • +4 more
  • 3T MRI Scanner
  • Miami, Florida
    University of Miami
Mar 15, 2022

Space Occupying Lesions of the Brain

Recruiting
  • Brain Tumor
  • +2 more
  • MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
  • Bern, Switzerland
    Institute for Diagnostic and Interventional Neuroradiology, Univ
Jan 26, 2023

Glioma Grading and Genotyping

Recruiting
  • Glioma
    • Chongqing, Chongqing, China
      Sang Zifan
    Aug 29, 2023

    Acute Kidney Injury Trial in Montpellier (Fiber-optic probe CeVOX)

    Not yet recruiting
    • Acute Kidney Injury
    • Fiber-optic probe CeVOX
    • Montpellier, France
      UH of Montpellier
    Jun 1, 2023

    Progressive Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic

    Not yet recruiting
    • Progressive Pulmonary Fibrosis
    • Interstitial Lung Disease
    • Placebo
    • +2 more
    • (no location specified)
    Jul 5, 2023

    Hidradenitis Suppurativa Trial in Aarhus (RGRN-305, Placebo)

    Completed
    • Hidradenitis Suppurativa
    • Aarhus, Denmark
      Aarhus University Hospital
    Jan 30, 2023

    RRMM, Other Plasma Cell Diseases Trial (LM-305, Dexamethasone)

    Not yet recruiting
    • RRMM
    • Other Plasma Cell Diseases
    • (no location specified)
    Dec 1, 2022

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Intradialytic Hypotension Trial (Icatibant, Placebo)

    Not yet recruiting
    • Intradialytic Hypotension
    • (no location specified)
    Apr 17, 2023

    Influencing Factors of Hypotension in Diabetic Patients

    Recruiting
    • Hemodialysis
    • Diabetes
    • This is an observational study
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Apr 6, 2022

    Adult Gliomas, Mixed Trial in San Francisco (Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG), Magnetic Resonance Image

    Recruiting
    • Adult Gliomas, Mixed
    • Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)
    • Magnetic Resonance Image (MRI)
    • San Francisco, California
      University of California, San Francisco
    May 9, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

    Not yet recruiting
    • Recurrent Glioblastoma, IDH-Wildtype
    • +2 more
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    May 13, 2023

    Glioma Trial in Paris (MRI)

    Not yet recruiting
    • Glioma
    • MRI
    • Paris, France
      Pitié-Salpetrière Hospital
    Jan 27, 2023

    Intradialytic Hypotension Trial in Cairo (L Carnitine)

    Active, not recruiting
    • Intradialytic Hypotension
    • L Carnitine
    • Cairo, Egypt
      Radwa Maher El Borolossy
    Jun 14, 2023

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell Trial in China (LOXO-305)

    Active, not recruiting
    • Leukemia, Lymphoid
    • +6 more
    • Wuhu, Anhui, China
    • +22 more
    Dec 8, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Bendamustine, Rituximab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Los Angeles, California
    • +142 more
    Jan 10, 2023

    Single Photon Emission Computed Tomography/Computed Tomography

    Not yet recruiting
    • Brain Glioma
    • SPECT with pentavalent 99mTc DMSA
    • (no location specified)
    Oct 23, 2022

    Astrocytoma Trial (Vorasidenib, Pembrolizumab)

    Not yet recruiting
    • Astrocytoma
    • (no location specified)
    Aug 1, 2022